This is not the most recent version of the article. View current version (21 MAY 2015)

Intervention Protocol

Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention

  1. Chen Mao1,
  2. Zu-Yao Yang1,
  3. Vincent CH Chung2,
  4. Ying Qin1,
  5. Wilson Tam1,
  6. Joey SW Kwong3,
  7. Wei Xie4,
  8. Jin Ling Tang5,*,
  9. Yafang Huang1,
  10. Jin-Qiu Yuan1

Editorial Group: Cochrane Heart Group

Published Online: 12 DEC 2012

DOI: 10.1002/14651858.CD010237


How to Cite

Mao C, Yang ZY, Chung VCH, Qin Y, Tam W, Kwong JSW, Xie W, Tang JL, Huang Y, Yuan JQ. Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD010237. DOI: 10.1002/14651858.CD010237.

Author Information

  1. 1

    The Chinese University of Hong Kong, Division of Epidemiology, School of Public Health and Primary Care, Hong Kong, China

  2. 2

    Chinese University of Hong Kong, Jockey Club School of Public Health and Primary Care, NT, Hong Kong, Hong Kong

  3. 3

    The Chinese University of Hong Kong, Division of Cardiology & Heart Education And Research Training (HEART) Centre, Department of Medicine and Therapeutics, Prince of Wales Hospital, & Institute of Vascular Medicine, Shatin, New Territories, Hong Kong

  4. 4

    School of Chinese Medicine, Southern Medical University, Chinese Medicine, Guangzhou, Guangdong, China

  5. 5

    The Chinese University of Hong Kong, School of Public Health and Primary Care, New Territories, Hong Kong, China

*Jin Ling Tang, School of Public Health and Primary Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Satin, New Territories, Hong Kong, China. jltang@cuhk.edu.hk.

Publication History

  1. Publication Status: New
  2. Published Online: 12 DEC 2012

SEARCH

This is not the most recent version of the article. View current version (21 MAY 2015)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To systematically assess the efficacy and safety of Tong-xin-luo capsules in preventing cardiovascular events for patients with coronary heart disease after PCI.